Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration.: HP5-141/1-1-2022E-PDF ; HP5-141/2-1-2022E-PDF
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.917987&sl=0
| Department/Agency | Public Health Agency of Canada, issuing body. Canada. National Advisory Committee on Immunization, issuing body. |
|---|---|
| Title | Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration. |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Earlier edition | Recommendations on the use of a first booster dose of Pfizer-BioNTech Comirnaty COVID-19 vaccine in children 5 to 11 years of age. |
| Format | Electronic |
| Electronic document |
|
| Note(s) | Issued also in French under title: Recommandations mises à jour sur l'utilisation des doses de rappel du vaccin contre la COVID-19 chez les enfants de 5 à 11 ans et sur l'administration concomitante de vaccins. On cover: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI). "Pub.: 220625." "Pub.: 220627." Includes bibliographical references (pages 18-24). |
| Publishing information | Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, December 9, 2022. ©2022 |
| Description | 1 online resource (24 pages) + summary (5 pages) |
| ISBN | 9780660465814 9780660465821 |
| Catalogue number |
|
| Departmental catalogue number | 220625 220627 |
| Subject terms | COVID-19 vaccines -- Canada. COVID-19 (Disease) -- Vaccination -- Canada. Vaccination of children -- Canada. COVID-19 vaccines -- Government policy -- Canada. COVID-19 (Disease) -- Vaccination -- Government policy -- Canada. Vaccination of children -- Government policy -- Canada. |